Assenagon Asset Management S.A. Takes Position in Cytokinetics, Incorporated (NASDAQ:CYTK) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Assenagon Asset Management S.A. Invests $46.31 Million in Cytokinetics, Incorporated (NASDAQ:CYTK) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Cytokinetics, Incorporated (NASDAQ:CYTK) Shares Sold by Dana Investment Advisors Inc. theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Cytokinetics (NASDAQ:CYTK – Free Report) had its target price decreased by Mizuho from $103.00 to $99.00 in a research report report published on Wednesday morning, Benzinga reports. Mizuho currently has a buy rating on the biopharmaceutical company’s stock. CYTK has been the topic of several other reports. B. Riley began coverage on Cytokinetics in a […]
Cytokinetics (NASDAQ:CYTK – Get Free Report) issued its earnings results on Tuesday. The biopharmaceutical company reported ($1.38) earnings per share for the quarter, missing the consensus estimate of ($1.03) by ($0.35), Briefing.com reports. The company had revenue of $1.70 million for the quarter, compared to analysts’ expectations of $7.62 million. The firm’s quarterly revenue was […]
Cytokinetics (NASDAQ:CYTK) Releases Earnings Results, Misses Estimates By $0.35 EPS theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) was the target of a significant decrease in short interest in the month of January. As of January 15th, there was short interest totalling 13,750,000 shares, a decrease of 8.8% from the December 31st total of 15,080,000 shares. Currently, 14.7% of the company’s stock are short sold. Based […]
Cytokinetics (NASDAQ:CYTK) Upgraded at StockNews.com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) was the target of some unusual options trading on Thursday. Stock investors acquired 36,208 call options on the company. This is an increase of 350% compared to the average volume of 8,049 call options. Insider Activity at Cytokinetics In related news, CEO Robert I. Blum sold 12,500 shares […]
Brokerages Set Cytokinetics, Incorporated (NASDAQ:CYTK) PT at $59.86 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.